Equity

Profit & Loss Home > Equity > Corporate Information > Profit & Loss

Fredun Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:539730 P/E (TTM) :42.86
ISIN Demat:INE194R01017 Div & Yield %:0.03 EPS (TTM) :60.24
Book Value (RS) :489.430006 Market Cap (Rs Cr.):1423.32 Face Value (RS) :10
    Change Company 
(Rs In Cr)
 Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
INCOME :      
Sales Turnover 635.47453.82348.16274.68224.46133.89
Excise Duty0.000.000.000.000.000.00
Net Sales635.47453.82348.16274.68224.46133.89
Other Income 3.662.450.921.821.631.40
Stock Adjustments 31.69-6.0522.4437.720.01-1.17
Total Income670.82450.22371.52314.22226.10134.12
EXPENDITURE :      
Raw Materials 480.76321.89282.42245.57176.45100.60
Power & Fuel Cost5.354.794.033.173.683.32
Employee Cost 32.9422.2312.5011.5410.668.66
Other Manufacturing Expenses 17.6617.1711.688.086.593.87
Selling & Administrative Expenses 36.7226.4220.7714.5512.767.80
Miscellaneous Expenses 2.592.631.221.710.460.28
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure576.02395.12332.61284.62210.60124.54
Operating Profit94.8055.1038.9029.6015.509.58
Interest 39.3022.3813.659.284.744.37
Gross Profit55.5032.7225.2520.3210.765.21
Depreciation7.914.453.802.812.162.00
Profit Before Tax47.5928.2721.4517.518.603.21
Tax12.317.125.544.292.210.76
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax2.060.350.292.410.050.44
Reported Net Profit33.2120.8115.6210.816.342.01
Extraordinary Items 0.000.000.000.000.000.00
Adjusted Net Profit33.2120.8115.6210.816.342.01
Adjustment below Net Profit 0.17-20.81-0.070.050.020.00
P & L Balance brought forward63.9163.9128.5518.0011.9310.18
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 0.330.000.330.310.280.27
P & L Balance carried down96.9563.9143.7728.5518.0011.93
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %7.007.007.007.007.007.00
Dividend Per Share(Rs)0.700.700.700.700.700.70
Earnings Per Share-Unit Curr60.6844.0733.2523.8414.295.05
Earnings Per Share(Adj)-Unit Curr60.6844.0733.2523.8414.295.05
Book Value-Unit Curr483.87299.47255.15194.27153.07107.96
Book Value(Adj)-Unit Curr483.87299.47255.15194.27153.07107.96
Thursday, June 25, 2026 10:48:00 AM
Adani Ports1817.30comprofit(0.22)%
      
Asian Paints2678.65comprofit(0.43)%
      
Axis Bank1388.90comprofit(0.35)%
      
Bajaj Finance998.70comprofit(0.80)%
      
Bajaj Finserv1786.30comprofit(0.33)%
      
Bharat Electro..411.00comprofit(-0.66)%
      
Bharti Airtel1869.75comprofit(-0.39)%
      
Eternal255.65comprofit(-0.25)%
      
HCL Technologi..1120.25comprofit(0.62)%
      
HDFC Bank798.85comprofit(0.72)%
      
Hind. Unilever2182.75comprofit(1.16)%
      
ICICI Bank1387.60comprofit(0.99)%
      
Infosys1052.00comprofit(-0.42)%
      
Interglobe Avi..5434.00comprofit(4.43)%
      
ITC291.05comprofit(0.28)%
      
Kotak Mah. Ban..410.70comprofit(1.16)%
      
Larsen & Toubr..4229.55comprofit(1.13)%
      
M & M3171.45comprofit(3.49)%
      
Maruti Suzuki13830.65comprofit(4.37)%
      
NTPC356.90comprofit(-0.03)%
      
Power Grid Cor..285.20comprofit(-1.93)%
      
Reliance Indus..1326.00comprofit(0.94)%
      
SBI1050.00comprofit(1.48)%
      
Sun Pharma.Ind..1883.85comprofit(0.49)%
      
Tata Steel189.25comprofit(-0.47)%
      
TCS2137.95comprofit(1.38)%
      
Tech Mahindra1455.70comprofit(-0.38)%
      
Titan Company4247.05comprofit(-1.93)%
      
Trent3278.05comprofit(0.98)%
      
UltraTech Cem.11546.35comprofit(0.94)%
      

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)